ST6GAL2 and breast cancer: Overall, increased ST6Gal II expression correlated positively with focal adhesion and metastasis pathways, whereas downregulating ST6Gal II expression led to reduced cell adhesion and invasion, leading the authors to propose that ST6Gal II is a potent oncogene and a potential target for treating breast cancer.